ConductScience.org, home
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
API referenceFor AI assistants

Trial · NCT00968708

Adverse events1,464

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1,101 to 1,120 of 1,464

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousOsteoarthritisMusculoskeletal and connective tissue disordersPlacebo32,679
seriousOsteoarthritisMusculoskeletal and connective tissue disordersAlogliptin32,701
seriousSpinal osteoarthritisMusculoskeletal and connective tissue disordersPlacebo32,679
seriousSpinal osteoarthritisMusculoskeletal and connective tissue disordersAlogliptin12,701
seriousIntervertebral disc disorderMusculoskeletal and connective tissue disordersPlacebo12,679
seriousIntervertebral disc disorderMusculoskeletal and connective tissue disordersAlogliptin22,701
seriousIntervertebral disc protrusionMusculoskeletal and connective tissue disordersPlacebo22,679
seriousIntervertebral disc protrusionMusculoskeletal and connective tissue disordersAlogliptin02,701
seriousMyopathyMusculoskeletal and connective tissue disordersPlacebo12,679
seriousMyopathyMusculoskeletal and connective tissue disordersAlogliptin12,701
seriousRotator cuff syndromeMusculoskeletal and connective tissue disordersPlacebo12,679
seriousRotator cuff syndromeMusculoskeletal and connective tissue disordersAlogliptin12,701
seriousArthralgiaMusculoskeletal and connective tissue disordersPlacebo02,679
seriousArthralgiaMusculoskeletal and connective tissue disordersAlogliptin12,701
seriousArthritisMusculoskeletal and connective tissue disordersPlacebo02,679
seriousArthritisMusculoskeletal and connective tissue disordersAlogliptin12,701
seriousBursitisMusculoskeletal and connective tissue disordersPlacebo12,679
seriousBursitisMusculoskeletal and connective tissue disordersAlogliptin02,701
seriousChondrocalcinosis pyrophosphateMusculoskeletal and connective tissue disordersPlacebo12,679
seriousChondrocalcinosis pyrophosphateMusculoskeletal and connective tissue disordersAlogliptin02,701

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=56

API referenceFor AI assistants